Genetic Technology Alert. Novel Antibody Dependent Cellular Cytotoxicity Enhancement Technology; Efficient Mammalian Cell Culture Technology Platform for Protein Production; Algae-Based Purification Platform for Mammalian Cell Harvesting

USD 250

* Required Fields

USD 250

PAY BY INVOICE

Be the first to review this product

This issue profiles novel antibody dependent cellular cytotoxicity enhancement technology, an efficient mammalian cell culture technology platform for protein production, and an algae-based purification platform for mammalian cell harvesting.

Table of Contents

Genetic Technology Alert. Novel Antibody Dependent Cellular Cytotoxicity Enhancement Technology; Efficient Mammalian Cell Culture Technology Platform for Protein Production; Algae-Based Purification Platform for Mammalian Cell HarvestingIn This Issue1. NOVEL ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY ENHANCEMENT TECHNOLOGY2. EFFICIENT MAMMALIAN CELL CULTURE TECHNOLOGY PLATFORM FOR PROTEIN PRODUCTION3. ALGAE-BASED PURIFICATION PLATFORM FOR MAMMALIAN CELL HARVESTING4. KEY PATENTS IN MAMMALIAN CELL CULTURE




Related Research

Release Date : 08-Sep-17

Region : Global

Release Date : 08-Sep-17

Region : Global

Release Date : 01-Sep-17

Region : Global

Release Date : 25-Aug-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.